Increasing the competitiveness of the company through implementation in the production of new veterinary preparations (Q104269): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Created claim: summary (P836): The project aims to increase the competitiveness and scale of ‘Biovet PULAWY’ sp. z o.o. (hereinafter Biovet) through the implementation of R & D results in innovative products: diagnostic preparations for the detection of tuberculosis in animals — Avituberculins and Bovituberculins. The novel products recipe and their production technology were developed as a result of the R & D work carried out, which lasted 6 years and resulted in the obtaini...) |
||
| Property / summary | |||
The project aims to increase the competitiveness and scale of ‘Biovet PULAWY’ sp. z o.o. (hereinafter Biovet) through the implementation of R & D results in innovative products: diagnostic preparations for the detection of tuberculosis in animals — Avituberculins and Bovituberculins. The novel products recipe and their production technology were developed as a result of the R & D work carried out, which lasted 6 years and resulted in the obtaining of marketing authorisations by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Biovet will be the only Polish producer of tuberculins in the industry. Bio-based preparations will be an innovative product at least on a national scale, in view of the quality and safety of the final product. The main dominance of the Avi- and Bovituberculins technological process: — use for the production of appropriately selected substrates, which do not have a negative impact on the end-use characteristics of the product, the use of which has a low ballast protein content affecting allergic reactions and the final result of the safety use test, which is the result of a thorough in vivo quality control. The introduction of new products on the market will be made possible by means of project and investment in works and new fixed assets relating to construction and equipment of the animal as an essential part of the production process of new preparations and associated quality control of the products. The activity is described in section. D1 of the application. The target groups: current and new customers of Biovet on the Polish and foreign markets: wholesalers and distributors of veterinary medicines and preparations. See project indicators in Section C.II and C.III. (English) | |||
| Property / summary: The project aims to increase the competitiveness and scale of ‘Biovet PULAWY’ sp. z o.o. (hereinafter Biovet) through the implementation of R & D results in innovative products: diagnostic preparations for the detection of tuberculosis in animals — Avituberculins and Bovituberculins. The novel products recipe and their production technology were developed as a result of the R & D work carried out, which lasted 6 years and resulted in the obtaining of marketing authorisations by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Biovet will be the only Polish producer of tuberculins in the industry. Bio-based preparations will be an innovative product at least on a national scale, in view of the quality and safety of the final product. The main dominance of the Avi- and Bovituberculins technological process: — use for the production of appropriately selected substrates, which do not have a negative impact on the end-use characteristics of the product, the use of which has a low ballast protein content affecting allergic reactions and the final result of the safety use test, which is the result of a thorough in vivo quality control. The introduction of new products on the market will be made possible by means of project and investment in works and new fixed assets relating to construction and equipment of the animal as an essential part of the production process of new preparations and associated quality control of the products. The activity is described in section. D1 of the application. The target groups: current and new customers of Biovet on the Polish and foreign markets: wholesalers and distributors of veterinary medicines and preparations. See project indicators in Section C.II and C.III. (English) / rank | |||
Normal rank | |||
Revision as of 09:15, 9 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increasing the competitiveness of the company through implementation in the production of new veterinary preparations |
Project in Poland financed by DG Regio |
Statements
1,564,855.46 zloty
0 references
9,923,039.62 zloty
0 references
2,381,529.5087999995 Euro
0.24 Euro
13 January 2020
0 references
60.0 percent
0 references
2 May 2018
0 references
31 December 2019
0 references
"BIOWET PUŁAWY" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
0 references
Celem projektu jest wzrost konkurencyjności oraz skali prowadzenia działalności "BIOWET PUŁAWY" sp. z o.o. (dalej:BIOWET) poprzez wdrożenie wyników prac B+R w postaci innowacyjnych produktów: preparatów diagnostycznych do wykrywania gruźlicy u zwierząt - Avituberculin i Bovituberculin. Receptura nowych produktów oraz ich technologia wytwarzania zostały opracowane w wyniku przeprowadzonych prac B+R, które trwały 6 lat i zakończyły się uzyskaniem pozwoleń na dopuszczenie do obrotu przez Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Biobójczych. Biowet będzie jedynym polskim producentem tuberkulin w branży. Preparaty Biowetu będą innowacyjnym produktem co najmniej na skalę kraju ze względu na jakość i bezpieczeństwo produktu finalnego. Najważniejsze dominanty procesu technologicznego Avi- i Bovituberculin: -wykorzystanie do produkcji odpowiednio dobranych podłoży, które nie mają negatywnego wpływu na właściwości użytkowe końcowego produktu -zastosowanie filtracji, dzięki której produkty mają małą zawartość białka balastowego wpływającego na reakcje alergiczne i wynik końcowy testu -zapewnienie bezpieczeństwa użycia, które jest wynikiem wnikliwej kontroli jakości prowadzonej in vivo. Wprowadzenie nowych produktów na rynek będzie możliwe dzięki realizacji projektu i inwestycjom w roboty budowlane oraz nowe środki trwałe związane z budową i wyposażeniem Zwierzętarni stanowiącej niezbędny element procesu produkcyjnego nowych preparatów i związaną z nim kontrolą jakości produktów. Zadanie opisano w pkt. D1 wniosku. Grupy docelowe: obecni oraz nowi odbiorcy BIOWET na rynku polskim i zagranicznym: hurtownie i dystrybutorzy leków i preparatów weterynaryjnych. Wskaźniki projektu zob. w sekcji C.II i C.III. (Polish)
0 references
The project aims to increase the competitiveness and scale of ‘Biovet PULAWY’ sp. z o.o. (hereinafter Biovet) through the implementation of R & D results in innovative products: diagnostic preparations for the detection of tuberculosis in animals — Avituberculins and Bovituberculins. The novel products recipe and their production technology were developed as a result of the R & D work carried out, which lasted 6 years and resulted in the obtaining of marketing authorisations by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Biovet will be the only Polish producer of tuberculins in the industry. Bio-based preparations will be an innovative product at least on a national scale, in view of the quality and safety of the final product. The main dominance of the Avi- and Bovituberculins technological process: — use for the production of appropriately selected substrates, which do not have a negative impact on the end-use characteristics of the product, the use of which has a low ballast protein content affecting allergic reactions and the final result of the safety use test, which is the result of a thorough in vivo quality control. The introduction of new products on the market will be made possible by means of project and investment in works and new fixed assets relating to construction and equipment of the animal as an essential part of the production process of new preparations and associated quality control of the products. The activity is described in section. D1 of the application. The target groups: current and new customers of Biovet on the Polish and foreign markets: wholesalers and distributors of veterinary medicines and preparations. See project indicators in Section C.II and C.III. (English)
0 references
Identifiers
RPLU.03.07.00-06-0010/17
0 references